数据链接：
官方服务：
资源简介：
ADWG by treatment group and challenge dose.
应用场景：
创建时间：
2018-12-28
相关数据集
Supplementary Material for: Short-term safety and efficacy of intravitreal brolucizumab injections for neovascular age-related macular degeneration: a multicenter retrospective real-world study
Introduction: To determine the short-term real-world safety and efficacy of intravitreal brolucizumab injections in Korean patients with neovascular age-related macular degeneration (nAMD). Methods: T
DataCite Commons2023-06-15 更新110
Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3
Purpose: To evaluate short- and long-term efficacy and safety of ixekizumab in patients according to psoriasis severity. Materials and methods: Data were integrated from clinical trials
DataCite Commons2020-08-29 更新70
The relative response and the relative index of the identified regimes of denosumab treatment.
Note 1: the pamidronate regime consisting of the intravenous administration of 90 mg pamidronate every 4 weeks for a period of 2 years is used as a base.
Figshare2015-12-02 更新40
Supplementary Material for: Efficacy and Safety of Glibenclamide on Functional Outcomes and Cerebral Edema Following Ischemic and Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Objective: This systematic review and meta-analysis aims to evaluate the clinical and radiological outcomes of glibenclamide versus control in acute stroke. Methods: In accordance with PRISMA guidelin
DataCite Commons2025-07-25 更新90
Subjective and objective sleep parameters at baseline and during nights of treatment with trial medication.
Subjective and objective sleep parameters at baseline and during nights of treatment with trial medication.
NIAID Data Ecosystem70
